RCM
CLVS

RA Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

RA Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13,200
Closed -$1.16M – 68
2015
Q2 		$1.16M Buy
+13,200
New +$1.13M 0.12% 48

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RA Capital Management's CLVS Position: Q3 2015 in Review

RA Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2015, closing a stake of 13,200 shares — an estimated $1.16M sold.

RA Capital Management first reported a position in CLVS in Q2 2015 and held it in 1 quarter. The position peaked at $1.16M in Q2 2015. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2015.

  • RA Capital Management reported no remaining Clovis Oncology, Inc. position as of Q3 2015 after selling out during the quarter.
  • RA Capital Management sold 13,200 Clovis Oncology, Inc. shares in Q3 2015, an estimated $1.16M.
  • RA Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2015 and held it in 1 quarter.
  • RA Capital Management's Clovis Oncology, Inc. position peaked at $1.16M in Q2 2015.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2015.

Based on RA Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.